Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain.

Advances in experimental medicine and biology

Volumn 611, Issue , 2009, Pages 545-546

  McMurray, John S ^a   Mandal, Pijus K ^a   Liao, Warren S ^a   Ren, Zhiyong ^a   Chen, Xiaomin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PRODRUG; STAT3 PROTEIN;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; MOLECULAR MIMICRY; PHOSPHORYLATION; SRC HOMOLOGY DOMAIN; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; MOLECULAR MIMICRY; PEPTIDES; PHOSPHORYLATION; PRODRUGS; SRC HOMOLOGY DOMAINS; STAT3 TRANSCRIPTION FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 66349123936     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-0-387-73657-0_239     Document Type: Article

References (0)